WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...
Cigna Corporation's Hong Kong business has announced that its Cigna Plus Medical Plan health insurance pr...
Burning Rock recently held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 mil...
Innovent Biologics, Inc. (Innovent) , a world-class biopharmaceutical company that develops, manufactures and commercial...
Ascletis Pharma through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Bio...
3SBio and Verseau Therapeutics have announced a partnership agreement focused on the development and commercialization o...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Samsung Bioepis Co., Ltd. has announced its expansion in mainland China through a licensing agreement with C-Bridge Capi...
Contraceptive market sales were estimated to be $6.3bn across the 8MM (US, France, Germany, Italy, Spain, UK, Japan...
The Lunar New Year welcomes a focus on the wellbeing of the entire body leading to renewed discussions about the benefit...
CStone Pharmaceutical and IMPACT Therapeutics, Inc. have jointly announced that an Investigational New Drug (IND) filing...
Invitrocue, a leading healthcare bio-analytic solutions provider, has announced the signing of a new technology developm...
Glenmark Pharmaceuticals Ltd. (Glenmark) has announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered i...
EdiGene Inc., headquartered in Beijing, with operational subsidiaries in Guangzhou, China and Cambridge, USA and which d...
Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange tra...
Accuray Asia Limited, a subsidiary of Accuray Incorporated, and CNNC High Energy Equipment (Tianjin) Co., Ltd, a subsidi...
CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for ca...
